Logo image of NNY

NUVEEN NEW YORK MUNI VAL (NNY) Stock Overview

USA - NYSE:NNY - US67062M1053

8.41 USD
-0.05 (-0.59%)
Last: 10/17/2025, 11:40:44 AM
Fundamental Rating

3

Taking everything into account, NNY scores 3 out of 10 in our fundamental rating. NNY was compared to 0 industry peers in the Unkown industry. NNY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NNY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NNY was profitable.
In multiple years NNY reported negative net income over the last 5 years.
In multiple years NNY reported negative operating cash flow during the last 5 years.
NNY Yearly Net Income VS EBIT VS OCF VS FCFNNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The 3 year average ROIC (2.10%) for NNY is below the current ROIC(3.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.98%
ROE 2.98%
ROIC 3.1%
ROA(3y)-1.88%
ROA(5y)0.59%
ROE(3y)-1.89%
ROE(5y)0.61%
ROIC(3y)2.1%
ROIC(5y)2.27%
NNY Yearly ROA, ROE, ROICNNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

In the last couple of years the Profit Margin of NNY has declined.
In the last couple of years the Operating Margin of NNY has remained more or less at the same level.
NNY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 87.04%
PM (TTM) 66.23%
GM 88.61%
OM growth 3Y0.64%
OM growth 5Y0.15%
PM growth 3YN/A
PM growth 5Y-3.75%
GM growth 3Y0.79%
GM growth 5Y0.31%
NNY Yearly Profit, Operating, Gross MarginsNNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, NNY has more shares outstanding
The number of shares outstanding for NNY has been increased compared to 5 years ago.
There is no outstanding debt for NNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NNY Yearly Shares OutstandingNNY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NNY Yearly Total Debt VS Total AssetsNNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

NNY has an Altman-Z score of 152.33. This indicates that NNY is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for NNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 152.33
ROIC/WACCN/A
WACCN/A
NNY Yearly LT Debt VS Equity VS FCFNNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 7.79 indicates that NNY has no problem at all paying its short term obligations.
NNY has a Quick Ratio of 7.79. This indicates that NNY is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 7.79
Quick Ratio 7.79
NNY Yearly Current Assets VS Current LiabilitesNNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

The earnings per share for NNY have decreased strongly by -47.06% in the last year.
The earnings per share for NNY have been decreasing by -16.55% on average. This is quite bad
Looking at the last year, NNY shows a small growth in Revenue. The Revenue has grown by 3.80% in the last year.
NNY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.64% yearly.
EPS 1Y (TTM)-47.06%
EPS 3YN/A
EPS 5Y-16.55%
EPS Q2Q%-72.22%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-12.15%
Revenue growth 5Y-9.64%
Sales Q2Q%2.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NNY Yearly Revenue VS EstimatesNNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.15, NNY can be considered very expensive at the moment.
Compared to an average S&P500 Price/Earnings ratio of 27.29, NNY is valued at the same level.
Industry RankSector Rank
PE 31.15
Fwd PE N/A
NNY Price Earnings VS Forward Price EarningsNNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNY Per share dataNNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

NNY has a Yearly Dividend Yield of 3.90%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.38, NNY pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.9%

5.2 History

NNY has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NNY Yearly Dividends per shareNNY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

NNY has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-124.7%
EPS Next 2YN/A
EPS Next 3YN/A
NNY Yearly Income VS Free CF VS DividendNNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

NUVEEN NEW YORK MUNI VAL

NYSE:NNY (10/17/2025, 11:40:44 AM)

8.41

-0.05 (-0.59%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners24.17%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap158.86M
Analysts84
Price TargetN/A
Short Float %0.07%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 3.9%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-124.7%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.0295)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.15
Fwd PE N/A
P/S 20.79
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)0.27
EY3.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS8.97
TBVpS8.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.98%
ROE 2.98%
ROCE 3.93%
ROIC 3.1%
ROICexc 3.1%
ROICexgc 3.1%
OM 87.04%
PM (TTM) 66.23%
GM 88.61%
FCFM N/A
ROA(3y)-1.88%
ROA(5y)0.59%
ROE(3y)-1.89%
ROE(5y)0.61%
ROIC(3y)2.1%
ROIC(5y)2.27%
ROICexc(3y)2.11%
ROICexc(5y)2.28%
ROICexgc(3y)2.11%
ROICexgc(5y)2.28%
ROCE(3y)2.66%
ROCE(5y)2.88%
ROICexcg growth 3Y-14.74%
ROICexcg growth 5Y-11.7%
ROICexc growth 3Y-14.74%
ROICexc growth 5Y-11.7%
OM growth 3Y0.64%
OM growth 5Y0.15%
PM growth 3YN/A
PM growth 5Y-3.75%
GM growth 3Y0.79%
GM growth 5Y0.31%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.79
Quick Ratio 7.79
Altman-Z 152.33
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.06%
EPS 3YN/A
EPS 5Y-16.55%
EPS Q2Q%-72.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-12.15%
Revenue growth 5Y-9.64%
Sales Q2Q%2.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.74%
EBIT growth 3Y-11.58%
EBIT growth 5Y-9.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.11%
FCF growth 3YN/A
FCF growth 5Y8.5%
OCF growth 1Y177.11%
OCF growth 3YN/A
OCF growth 5Y8.5%